Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
AML, Adult, Biological, Diseases, Combinations, Elderly, Therapies, Pediatric, Biological Processes, enzyme inhibitors, Young Adult, Study Population, Myeloid Malignancies, Clinically relevant, hematopoiesis
Type: Oral
Hematology Disease Topics & Pathways:
AML, Adult, Biological, Diseases, Combinations, Elderly, Therapies, Pediatric, Biological Processes, enzyme inhibitors, Young Adult, Study Population, Myeloid Malignancies, Clinically relevant, hematopoiesis
Sunday, December 6, 2020: 12:00 PM-1:30 PM
Moderators:
Courtney D. DiNardo, MD, MSc, UT MD Anderson Cancer Center
and
Michael R. Grunwald, MD, Johns Hopkins University
Disclosures:
DiNardo: AbbVie: Consultancy, Honoraria, Research Funding; Takeda: Honoraria; Daiichi Sankyo: Consultancy, Honoraria, Research Funding; ImmuneOnc: Honoraria, Research Funding; Jazz: Honoraria; Agios: Consultancy, Honoraria, Research Funding; Celgene: Consultancy, Honoraria, Research Funding; Novartis: Consultancy; MedImmune: Honoraria; Calithera: Research Funding; Notable Labs: Membership on an entity's Board of Directors or advisory committees.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH